Director, FP&A


The Director of FP&A plays a key management role within the business and will act in both an operational and strategic manner with constant awareness of assumptions and performance issues that affect financial operations and forecasts. The FP&A Director will be contributing to the company’s strategic growth at a high level, yet will dig into the details of the finance results and modeling. Collaborating with the SVP/CFO and other executives on a daily basis, the Director of FP&A will work closely to deliver monthly briefings to the SVP/ CFO, perform thorough analysis of the key drivers of the business, maintain forecast models and drive the annual budget process for the business. The successful candidate will have strong technical and presentation skills, and experience with leading edge planning. The most successful candidates have thrived in environments with advanced ERP and CRM systems, and understand the power of leveraging these systems as the company scales. 


This list of duties and responsibilities is not all inclusive and may be expanded to include other duties and responsibilities, as management may deem necessary from time to time.


To perform this job successfully, an individual must be able to perform each essential duty satisfactorily. The requirements listed below are representative of the knowledge, skill, and/or ability required. Reasonable accommodations may be made to enable individuals with disabilities to perform the essential functions.




Pulse Biosciences is a novel medical therapy company bringing to market its proprietary CellFX™ Nano-Pulse Stimulation™ (NPS™) platform. The Company’s CellFX NPS platform provides a novel, precise, non-thermal, treatment technology delivering nanosecond duration energy pulses that impact cells in treated tissue while sparing acellular tissue. NPS’s unique mechanism of action disrupts the functions of internal cell structures while maintaining the outer cell membrane initiating a cascade of events within the cell that results in regulated cell death. The novel characteristics of the Company’s NPS mechanism of action has the potential to significantly benefit patients across multiple medical applications, including dermatology, the Company’s first planned commercial application. In pre-clinical studies, NPS has demonstrated an ability to induce immunogenic cell death in several cancer cell lines. The Company believes its NPS platform may play a role in immuno-oncology as a focal tumor treatment that can initiate an adaptive immune response. More information can be found at

Pulse Biosciences, Inc. (PLSE, Nasdaq) corporate headquarters is located in Hayward, CA.

Send resume to:

All qualified applicants will receive consideration for employment without regard to race, sex, color, religion, national origin, protected veteran status, or on the basis of disability, gender identity, and sexual orientation.